使用不同新型锝核心标记的[99mTc]cRGD肽的体外和体内特性比较。
Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
作者信息
Decristoforo C, Santos I, Pietzsch H J, Kuenstler J U, Duatti A, Smith C J, Rey A, Alberto R, Von Guggenberg E, Haubner R
机构信息
Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.
出版信息
Q J Nucl Med Mol Imaging. 2007 Mar;51(1):33-41.
AIM
The alfa(v)beta(3) integrin is involved in angiogenesis and tumor metastasis. Arginine-glycine-aspartic acid (RGD)-peptides bind with high affinity to this integrin. This study compares the influence of (99m)Tc-labeling applying novel Technetium-cores on imaging characteristics of the radiolabeled peptide.
METHODS
Different peptide conjugates based on the cyclic pentapeptide c(RGDyK) (cRGD) were prepared and characterized (HYNIC-, Cys-, L2- and Pz1-cRGD). Radiolabeling experiments using different coligands for HYNIC-cRGD, the (99m)Tc(CO)(3) metal fragment for PZ-1-cRGD (pyrazolyl-derivative), the Tc-nitrido-core using a phosphine-coligand (PNP) for Cys-cRGD and an isonitrile-conjugate (L2-cRGD) together with a NS(3)-coligand (4+1 concept) were performed and showed labeling yields >90% at high specific activities.
RESULTS
A high in vitro stability was observed, plasma protein binding and lipophilicity varied considerably between different radiolabeled cRGD conjugates. Experiments on biological activity of the radiolabeled peptides using alfa(v)beta(3) positive (M21) and negative (M21L) tumor cells did show specific uptake of various conjugates. Studies in tumor bearing animals revealed significant differences between different conjugates concerning pharmacokinetic behavior (predominant renal excretion to considerable hepatobiliary clearance) as well as tumor uptake (0.2-2.7%ID/g). Highest specific tumor uptake and tumor/background values were found for [(99m)Tc]EDDA/HYNIC-c(RGDyK), [(99m)Tc]Nitrido-PNP-Cys-c(RGDyK) and [(99m)Tc(CO)(3)]-Pz1-c(RGDyK).
CONCLUSIONS
Using novel Tc-cores such as the (99m)Tc(CO)(3) metal fragment, Tc-nitrido- and the 4+1 concept peptides could be labeled with [(99m)Tc]technetium at high specific activities resulting in complexes with high stability, but binding moieties have to be optimized especially concerning hydrophilicity resulting in renal rather than hepatobiliary excretion. This comparative study underlines that peptide labeling strategies using (99m)Tc have to be properly selected and optimized. Different in vitro assays are necessary to predict targeting properties in vivo.
目的
α(v)β(3)整合素参与血管生成和肿瘤转移。精氨酸 - 甘氨酸 - 天冬氨酸(RGD)肽能与该整合素高亲和力结合。本研究比较了应用新型锝核进行(99m)Tc标记对放射性标记肽成像特性的影响。
方法
制备并表征了基于环五肽c(RGDyK)(cRGD)的不同肽偶联物(HYNIC -、Cys -、L2 - 和Pz1 - cRGD)。使用针对HYNIC - cRGD的不同共配体、用于PZ - 1 - cRGD的(99m)Tc(CO)3金属片段(吡唑基衍生物)、使用膦共配体(PNP)的锝氮核用于Cys - cRGD以及异腈偶联物(L2 - cRGD)与NS(3)共配体进行放射性标记实验(4 + 1概念),并显示在高比活度下标记产率>90%。
结果
观察到高体外稳定性,不同放射性标记的cRGD偶联物之间血浆蛋白结合和脂溶性差异很大。使用α(v)β(3)阳性(M21)和阴性(M21L)肿瘤细胞对放射性标记肽的生物活性实验确实显示了各种偶联物的特异性摄取。在荷瘤动物中的研究揭示了不同偶联物在药代动力学行为(主要经肾排泄到相当程度的肝胆清除)以及肿瘤摄取(0.2 - 2.7%ID/g)方面的显著差异。[(99m)Tc]EDDA/HYNIC - c(RGDyK)、[(99m)Tc]氮化物 - PNP - Cys - c(RGDyK)和[(99m)Tc(CO)3] - Pz1 - c(RGDyK)的肿瘤特异性摄取和肿瘤/本底值最高。
结论
使用新型锝核,如(99m)Tc(CO)3金属片段、锝氮核和4 + 1概念,可以以高比活度用[(99m)Tc]锝标记肽,得到具有高稳定性的复合物,但结合部分必须特别针对亲水性进行优化,以实现经肾而非肝胆排泄。这项比较研究强调,使用(99m)Tc的肽标记策略必须正确选择和优化。需要不同的体外试验来预测体内靶向特性。